Paul R Michl

Array ( [id] => 3882397 [patent_doc_number] => 05798335 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Method for the treatment or prevention of eczema/dermatitis' [patent_app_type] => 1 [patent_app_number] => 8/619462 [patent_app_country] => US [patent_app_date] => 1996-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3634 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798335.pdf [firstpage_image] =>[orig_patent_app_number] => 619462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888456 [patent_doc_number] => 05723580 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Ketomethylene group-containing aldehyde cysteine and serine protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/646513 [patent_app_country] => US [patent_app_date] => 1996-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4964 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723580.pdf [firstpage_image] =>[orig_patent_app_number] => 646513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4076836 [patent_doc_number] => 05965698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site' [patent_app_type] => 1 [patent_app_number] => 8/532818 [patent_app_country] => US [patent_app_date] => 1996-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18429 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965698.pdf [firstpage_image] =>[orig_patent_app_number] => 532818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034028 [patent_doc_number] => 05942489 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'HGH-RH(1-29)NH2 analogues having antagonistic activity' [patent_app_type] => 1 [patent_app_number] => 8/642472 [patent_app_country] => US [patent_app_date] => 1996-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15288 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942489.pdf [firstpage_image] =>[orig_patent_app_number] => 642472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046731 [patent_doc_number] => 05912329 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Method for purification of a mixture of hydroxamate derivatized protein and native protein' [patent_app_type] => 1 [patent_app_number] => 8/635908 [patent_app_country] => US [patent_app_date] => 1996-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2130 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912329.pdf [firstpage_image] =>[orig_patent_app_number] => 635908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4168711 [patent_doc_number] => 06140159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Method for activating an ohmic layer for a thin film transistor' [patent_app_type] => 1 [patent_app_number] => 8/635862 [patent_app_country] => US [patent_app_date] => 1996-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 11 [patent_no_of_words] => 1874 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140159.pdf [firstpage_image] =>[orig_patent_app_number] => 635862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1312710 [patent_doc_number] => 06613875 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Cyclic peptide tube' [patent_app_type] => B1 [patent_app_number] => 08/632444 [patent_app_country] => US [patent_app_date] => 1996-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 44 [patent_no_of_words] => 16663 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613875.pdf [firstpage_image] =>[orig_patent_app_number] => 08632444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3863932 [patent_doc_number] => 05762923 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Stabilized interferon alpha solutions' [patent_app_type] => 1 [patent_app_number] => 8/627563 [patent_app_country] => US [patent_app_date] => 1996-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3649 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/762/05762923.pdf [firstpage_image] =>[orig_patent_app_number] => 627563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3852910 [patent_doc_number] => 05767237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Peptide derivatives' [patent_app_type] => 1 [patent_app_number] => 8/619606 [patent_app_country] => US [patent_app_date] => 1996-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5928 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767237.pdf [firstpage_image] =>[orig_patent_app_number] => 619606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979722 [patent_doc_number] => 05948765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Inhibition of intracellular signal transduction by 14-3-3-binding peptides' [patent_app_type] => 1 [patent_app_number] => 8/616669 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14280 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948765.pdf [firstpage_image] =>[orig_patent_app_number] => 616669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769910 [patent_doc_number] => 05849692 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/616770 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6547 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849692.pdf [firstpage_image] =>[orig_patent_app_number] => 616770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3862439 [patent_doc_number] => 05837265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Chemically-modified clostridiatoxin with improved properties' [patent_app_type] => 1 [patent_app_number] => 8/612571 [patent_app_country] => US [patent_app_date] => 1996-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 6687 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837265.pdf [firstpage_image] =>[orig_patent_app_number] => 612571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868963 [patent_doc_number] => 05837680 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis' [patent_app_type] => 1 [patent_app_number] => 8/602941 [patent_app_country] => US [patent_app_date] => 1996-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 12868 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837680.pdf [firstpage_image] =>[orig_patent_app_number] => 602941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985148 [patent_doc_number] => 05861486 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Collagen modulators for use in photoablation eximer laser keratectomy' [patent_app_type] => 1 [patent_app_number] => 8/602922 [patent_app_country] => US [patent_app_date] => 1996-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 38 [patent_no_of_words] => 9882 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861486.pdf [firstpage_image] =>[orig_patent_app_number] => 602922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888443 [patent_doc_number] => 05723579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Fibrinogen binding peptides' [patent_app_type] => 1 [patent_app_number] => 8/595718 [patent_app_country] => US [patent_app_date] => 1996-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 5688 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723579.pdf [firstpage_image] =>[orig_patent_app_number] => 595718 [rel_patent_id] =>[rel_patent_doc_number] =>)